Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-007717

Director acquired 301 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ASELAGE STEVE Director 2022-02-28 Grant or award +301 $16.61 $5,000 33,159 D
Loading xslF345X03/form4.xml…